comparemela.com

Latest Breaking News On - Gracell biotechnologie - Page 1 : comparemela.com

Reviewing Gracell Biotechnologies (NASDAQ:GRCL) and Evolva (OTCMKTS:ELVAF)

Reviewing Gracell Biotechnologies (NASDAQ:GRCL) and Evolva (OTCMKTS:ELVAF)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Reviewing Gracell Biotechnologies (NASDAQ:GRCL) & Evolva (OTCMKTS:ELVAF)

Gracell Biotechnologies (NASDAQ:GRCL – Get Free Report) and Evolva (OTCMKTS:ELVAF – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Insider & Institutional Ownership 22.0% of Evolva shares are […]

HC Wainwright Lowers Gracell Biotechnologies (NASDAQ:GRCL) to Neutral

HC Wainwright lowered shares of Gracell Biotechnologies (NASDAQ:GRCL – Free Report) from a buy rating to a neutral rating in a report released on Tuesday morning, MarketBeat reports. The firm currently has $10.00 target price on the stock, down from their prior target price of $13.00. HC Wainwright also issued estimates for Gracell Biotechnologies’ FY2026 […]

Gracell Biotechnologies (NASDAQ:GRCL) Downgraded by HC Wainwright to Neutral

HC Wainwright lowered shares of Gracell Biotechnologies (NASDAQ:GRCL – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat.com reports. HC Wainwright currently has $10.00 target price on the stock, down from their previous target price of $13.00. HC Wainwright also issued estimates for Gracell […]

AstraZeneca Buys Gracell Biotechnologies for $1 2B

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.